SYNB011128

N/A

Report date: 2025/04/30 09:58:12
NME

Base Information

Drug NameSYNB011128
Drug Alias NameSYNB011128SYNB-011128
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionEpidermal growth factor receptor erbB1 antagonistsCarbonic anhydrase IX inhibitorsTubulin polymerisation inhibitors
TargetsEpidermal growth factor receptor erbB1Carbonic anhydrase IXTubulin
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSyneron Bio
China Registration ClassN/A

Develop Information

Active CompaniesSyneron Bio
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungPancreatic NeoplasmsColonic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A